Patients received a new treatment for heart valve disease, which did not require riskier open-heart surgery or travel to ...

InterShunt Technologies announced today that it began an early feasibility study of its device for reducing heart failure symptoms.

Heart attack survival odds have dramatically improved over the past 5 decades, but more people are dying from chronic cardiac ...

Research shows heart attack deaths have plummeted by nearly 90% since 1970, while deaths from heart failure and arrhythmias ...

Brown University biologists found that when a protein called AIMP3 was removed from heart cells in mice, it led to severe ...

Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during ...

Traditional stents solve heart patients’ immediate, critical need for restoring arterial blood flow. However, because they ...

New findings by a team of molecular biologists at Brown University on the critical role of a protein called AIMP3 in heart ...

Verve Therapeutics’ stock was rallying by a record 80% on Eli Lilly’s premium purchase price for the drug-development company ...

Over the past 50 years, overall heart disease death rates have dropped by 66% and deaths from heart attacks have declined by ...

Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items ...

A group of researchers and engineers from the University of Colorado Boulder, the University of Colorado Anschutz Medical ...